XML 90 R72.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Mar. 13, 2025
Mar. 05, 2025
May 06, 2024
Mar. 13, 2024
Jan. 26, 2024
Oct. 17, 2023
Mar. 07, 2023
Jul. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Nov. 30, 2022
Mar. 28, 2022
Class of Stock [Line Items]                          
Preferred stock, per share                 $ 0.001 $ 0.001      
Common stock, shares issued                 63,071,950 42,329,864      
Common stock, shares outstanding                 63,071,950 42,329,864      
Number of shares issued for services                 790,000        
Number of common shares issued, value                 $ 641 $ 147      
Management Services Agreement [Member]                          
Class of Stock [Line Items]                          
Costs and expenses related party         $ 4,675                
Pavmed Inc [Member]                          
Class of Stock [Line Items]                          
Majority interest equity ownership shares                 31,302,444        
Common Stock [Member]                          
Class of Stock [Line Items]                          
Preferred stock converted shares                 2,075,263        
Authorized to issue shares description               the Company received shareholder approval to amend its certificate of incorporation, as amended, to increase the total number of shares of common stock the Company is authorized to issue by 100 million shares from 200 million shares to 300 million shares.          
Majority interest equity ownership shares                 63,071,950 42,329,864 40,518,792    
Number of shares issued for services                 790,000 100,000      
Number of common shares issued, value                 $ 1      
Common Stock [Member] | Subsequent Event [Member]                          
Class of Stock [Line Items]                          
Number of sale of stock shares   13,939,331                      
Stock price per share   $ 1.10                      
Net proceeds from sale of stock   $ 14,500                      
Common Stock [Member] | Minimum [Member]                          
Class of Stock [Line Items]                          
Weighted average price of common stock       $ 8.00                  
Pavmed Inc [Member]                          
Class of Stock [Line Items]                          
Number of shares of common stock         3,331,771                
Cantor Fitzgerald [Member] | Commited Equity Facility [Member]                          
Class of Stock [Line Items]                          
Common stock authorized for sale                         $ 50,000
Number of shares issued in ATM offering                 680,263        
Proceeds from issuance of common stock                 $ 1,800        
Percentage of discount on sale of stock                 4.00%        
Cantor Fitzgerald [Member] | Controlled Equity Offering Agreement [Member]                          
Class of Stock [Line Items]                          
Common stock authorized for sale                       $ 6,500  
Number of shares issued in ATM offering                 230,068        
Proceeds from issuance of shares in ATM offering                 $ 300        
Percentage of commission paid to broker                 3.00%        
Series B-1 Preferred Stock [Member]                          
Class of Stock [Line Items]                          
Number of sale of stock shares       12,495                  
Conversion price     $ 0.7228           $ 0.7228        
Gross proceeds from the sale of shares     $ 11,600                    
Preferred stock, shares issued     11,634           54,419        
Preferred stock converted shares                 1,500        
Preferred stock shares outstanding                 54,419        
Series B Preferred Stock [Member]                          
Class of Stock [Line Items]                          
Number of sale of stock shares       31,790                  
Preferred stock, per share       $ 0.001                  
Weighted average price of common stock       1,000                  
Preferred stock, stated value       1,000                  
Conversion price       $ 1.2444                  
Gross proceeds from the sale of shares       $ 18,200                  
Preferred stock dividend payment terms       Each holder of Series B Preferred Stock (i) was entitled to receive, and did receive, a dividend on or about March 13, 2025 equal to 20% of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder on March 13, 2025, and (ii) will be entitled to receive a dividend on or about March 13, 2026 equal to a number of shares of Common Stock equal to 20% of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder on March 13, 2026. A holder that voluntarily converts its Series B Preferred Stock prior to March 13, 2026 will not receive the dividend that accrues on such date with respect to such converted Series B Preferred Stock. The holders of the Series B Preferred Stock also will be entitled to dividends equal, on an as-if-converted to shares of Common Stock basis, to and in the same form as dividends actually paid on shares of the Common Stock when, as, and if such dividends are paid on shares of the Common Stock.                  
Conversion of stock, description       The Company will not effect any conversion of the Series B Preferred Stock, and a holder will not have the right to receive dividends or convert any portion of the Series B Preferred Stock, to the extent that, after giving effect to the receipt of dividends or the conversion, the holder (together with such holder’s affiliates, and any persons acting as a group together with such holder or any of the holder’s affiliates) would beneficially own in excess of 4.99% of the Company’s outstanding common stock (or, upon election of the holder, 9.99% of the Company’s outstanding common stock).                  
Preferred stock, shares issued                 54,419        
Preferred stock shares outstanding                 54,419        
Series B Preferred Stock [Member] | Subsequent Event [Member]                          
Class of Stock [Line Items]                          
Number of shares of common stock 7,117,463                        
Number of shares of common stock, percentage 20.00%                        
Series A Preferred Stock [Member]                          
Class of Stock [Line Items]                          
Number of sale of stock shares       13,625                  
Preferred stock, per share       $ 0.001     $ 0.001            
Conversion price             $ 1.394            
Right to receive dividend percentage       20.00%                  
Gross proceeds from the sale of shares             $ 13,600            
Preferred stock, shares issued             13,625     18,625      
Preferred stock shares outstanding                   18,625      
Series A-1 Preferred Stock [Member]                          
Class of Stock [Line Items]                          
Number of sale of stock shares       10,670                  
Preferred stock, per share       $ 0.001                  
Conversion price           $ 1.2592              
Gross proceeds from the sale of shares       $ 5,700   $ 5,000              
Preferred stock, shares issued       5,670   5,000       18,625      
Preferred stock shares outstanding       0           18,625      
Series A-1 Preferred Stock [Member] | Investor [Member]                          
Class of Stock [Line Items]                          
Number of sale of stock shares       5,670                  
Weighted average price of common stock       $ 1,000                  
Series B Convertible Preferred Stock [Member]                          
Class of Stock [Line Items]                          
Preferred stock dividends, shares                 31,790        
Series A and A-1 Convertible Preferred Stock [Member]                          
Class of Stock [Line Items]                          
Issuance of exchange subsidiary preferred stock series and series A one       $ 24,294                  
Fair value of deemed dividend       $ 7,500